Mycobacterium chelonae: Difference between revisions
Jump to navigation
Jump to search
Shanshan Cen (talk | contribs) |
Shanshan Cen (talk | contribs) |
||
| Line 30: | Line 30: | ||
:* Alternative regimen: [[Azithromycin]] | :* Alternative regimen: [[Azithromycin]] | ||
* Disseminated or extensive disease | * Disseminated or extensive disease | ||
:* monotherapy | |||
::* Preferred regimen: [[Clarithromycin]] 500 mg PO twice daily | |||
:* multidrug therapy | |||
::* preferred regimen: [[Clarithromycin]] 500 mg PO BID {{and}} [[Tobramycin]] 5 mg IV/kg/day {{or}} [[Imipenem]] 0.5-1 g IV q6h {{or}} [[Linezolid]] 600 mg IV/PO BID for 4-8 weeks | |||
::* Alternative regimen: [[Moxifloxacin]] 400 mg daily {{and}} [[Linezolid]] 600 mg twice daily | |||
:* NOTE: Total treatment duration is 6 months | |||
* Keratitis (LASIK-related) | * Keratitis (LASIK-related) | ||
Revision as of 00:52, 6 July 2015
| style="background:#Template:Taxobox colour;"|Mycobacterium chelonae | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| style="background:#Template:Taxobox colour;" | Scientific classification | ||||||||||||||
| ||||||||||||||
| Binomial name | ||||||||||||||
| Mycobacterium chelonae Bergey et al. 1923, ATCC 35752 |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2]
Overview
Mycobacterium chelonae is a species of the phylum actinobacteria (Gram-positive bacteria with high guanine and cytosine content, one of the dominant phyla of all bacteria), belonging to the genus mycobacterium.
Mycobacterium chelonae is a rapidly growing mycobacterium, that is found all throughout the environment including sewage and tap water. It can occasionally cause opportunistic infections of humans.
It is grouped in Runyon group IV.
Type strain: strain CM 6388 = ATCC 35752 = CCUG 47445 = CIP 104535 = DSM 43804 = JCM 6388 = NCTC 946.
Treatment
Antimicrobial regimen
- Localized infections
- Preferred regimen: Clarithromycin 500 mg PO twice daily
- Alternative regimen: Azithromycin
- Disseminated or extensive disease
- monotherapy
- Preferred regimen: Clarithromycin 500 mg PO twice daily
- multidrug therapy
- preferred regimen: Clarithromycin 500 mg PO BID AND Tobramycin 5 mg IV/kg/day OR Imipenem 0.5-1 g IV q6h OR Linezolid 600 mg IV/PO BID for 4-8 weeks
- Alternative regimen: Moxifloxacin 400 mg daily AND Linezolid 600 mg twice daily
- NOTE: Total treatment duration is 6 months
- Keratitis (LASIK-related)